The IOI Synergy Grants scheme is an internal Oxford-wide funding call for AMR-focused research with translational potential and with a strong focus on collaboration across university departments and disciplines.
Each project will receive funding of up to £500,000 over a two-year period. Projects include new antibiotic drug discovery, development of diagnostic tools to accurately diagnose infections, phages to kill drug-resistant bacteria, and behavior change interventions to reduce antibiotic usage.
Professor Sir Stewart Cole, Executive Chair of the IOI:
“AMR is a multi-faceted problem that cannot be solved by working in silos. Experts from medical sciences, life sciences and social sciences must work in unison to protect the existing antibiotics and find new ones. The IOI Synergy Grants bring together Oxford’s world-class researchers in an integrated multidisciplinary approach to shape the future of modern medicine.
The projects exemplify the tremendous range of AMR research across the university, from new diagnostic tools to patient-facing interventions. The quality of research is outstanding, and I look forward to seeing real-world applications arise from the IOI Synergy initiative.”
Read the full story on the Ineos Oxford Institute website.
more recommended stories
Harmful Chemicals in Children’s MattressesA recent study has brought to.
TMS for Post-Stroke Aphasia Shows Remarkable GainsA new clinical study led by.
CT Scan Overuse May Cause 1 in 20 New U.S. CancersA recent study published in JAMA.
Lactation Metabolism: Brain-Hormone Link UncoveredUnderstanding how the body adjusts to.
Quantum Technology in Cancer Surgery: New Probe Aims to Improve OutcomesA groundbreaking project from the University.
Bean-Based Gum Offers New Approach to Combat Influenza and HerpesIn an era where infectious diseases.
Shingles Vaccine May Cut Dementia Risk by 20%A new study shows that the.
New Study Questions Fluid Restriction in Heart Failure ManagementA groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic RegulationA groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%A recent rapid review suggests that.
Leave a Comment